RBR-57b63d尚未招募1 期
Assessment of primary and cumulative irritation potential, sensitization potential of the skin and the potential for phototoxicity and photoallergy of the skin supervised by Dermatologist for HG22 Vaginal Moisture Restorative Product
INFAN - Indústria Química e Farmacêutica Nacional0 个研究点开始时间: 2020年5月26日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Intervention
入排标准
- 年龄范围
- 18Y 至 65Y（—）
入选标准
- •Participants of both sexes; Age between 18 to 65 years; Phototypes: I, II, III and IV; Skin of the whole test region; Agreement to obey the trial procedures and attend the clinic on the days and times determined for medical evaluations and for application and reading of the dressings; Understand, consent and sign the Free and Informed Consent Form (ICF).
排除标准
- •Pregnancy or risk of pregnancy and / or lactation; (when women); Background atopic or allergic to health products; Use of anti-inflammatory drugs 30 days and / or immunosuppressive for up to three months before selection; Diseases that cause suppression of immunity, such as diabetes and HIV; Personal history of atopy; Intense sun exposure or tanning sessions up to 15 days before the evaluation; Prediction of intense exposure to sunlight or tanning sessions during the study period; Prediction of sea baths, pool or sauna during the study; Water sports practice during the study; 10) Dermographism (property that has the skin of certain individuals to swell and redden in the place where it is streaked by something relatively sharp); Use of oral or topical treatment with vitamin A acid and / or its derivatives up to 1 month before the beginning of the study; Aesthetic and / or dermatological treatment on the body within 03 weeks before selection; Vaccination scheduled during the study period or up to 03 weeks before selection; History of sensitization and irritation to a topical product; Active skin pathologies (local and / or disseminated) that may interfere with the results of the study; Use of new drugs, health products that are not part of the participant's routine during the study; Skin reactivity; Previous participation in studies with the same product; Known history or suspected intolerance to any ingredient in the study products (test or comparative products); History of lack of adherence or unwillingness to adhere to the study protocol; Other conditions considered by the evaluating physician as reasonable for the disqualification from participation in the study.
研究者
相似试验
尚未招募
Unknown
Dermatological test on revitalizing lotion and restorative lotioSkin agingG13.750RBR-3hnmbdtKosmoscience Ciência e Tecnologia Cosm Imp Exp Ltda
尚未招募
不适用
Dermatological Evaluation of HB22Photosensitivity disordersRBR-3rgpwgINFAN - Indústria Química e Farmacêutica Nacional
进行中（未招募）
不适用
Assessment of Primary and Accumulated Irritation Potential, Skin Sensitization Potential and Skin Allergy and Toxicity Potential by Ultraviolet Light Accompanied by a Dermatologist for the Gel Cream ProductHypersensitivityN06.850.210RBR-74b44vfKosmosciense Ciência e Tecnologia Cosm Imp Exp Ltda
尚未招募
Unknown
Human Repeat Insult Patch Test Study for evaluation of irritation and sensitisatioCTRI/2024/04/065893Zydus Lifesciences Limited
已完成
Unknown
Evaluation Of the Irritation and Sensitization Potential of Test Products in Healthy Adult Human SubjectsCTRI/2023/06/054569Himalaya Wellness Company201